앤드류 휴버먼: 펩타이드, 수면 기술, 그리고 비만의 종말
Daisy Wolf speaks with Dr. Andrew Huberman, professor of neurobiology and ophthalmology at Stanford University and host of the Huberman Lab podcast. They discuss how the pandemic sparked a consumer health revolution, the emerging peptide and GLP landscape, what the science actually says about focus drugs, and the neurotechnologies Huberman believes will let us write to our own biology within the next five years
출처 기사
Acquired Podcast (United States) | Mar 09, 2026
Your votes count
No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.
AI 번역 · 원문 보기
While focus drugs may enhance productivity, their long-term effects on mental health and societal norms should be critically examined.
AI 번역 · 원문 보기
The enthusiasm for sleep tech and neuroenhancements may overshadow the importance of fundamental lifestyle changes in achieving health.
AI 번역 · 원문 보기
The rise of peptide therapies represents a groundbreaking advancement in personalized medicine that could revolutionize obesity treatment.
AI 번역 · 원문 보기
Relying on neurotechnology to alter our biology risks oversimplifying complex health issues and could lead to unforeseen consequences.
AI 번역 · 원문 보기
The consumer health revolution sparked by the pandemic empowers individuals to take charge of their wellness through innovative technologies and treatments.
💡 How This Works
- • Add Statements: Post claims or questions (10-500 characters)
- • Vote: Agree, Disagree, or Unsure on each statement
- • Respond: Add detailed pro/con responses with evidence
- • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement
Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.
Support us